While these data are suggestive of an oncogenic role of ANGPTL4, other studies reported that both the levels of ANGPT4 mRNA and the copy number of the gene are lower in HCC samples than in non-tumor tissues of the same patients. This evidence concerns the gene ANGPTL4 and hepatocellular carcinoma.